SG11201811154QA - Method for producing diphenylmethane derivative - Google Patents

Method for producing diphenylmethane derivative

Info

Publication number
SG11201811154QA
SG11201811154QA SG11201811154QA SG11201811154QA SG11201811154QA SG 11201811154Q A SG11201811154Q A SG 11201811154QA SG 11201811154Q A SG11201811154Q A SG 11201811154QA SG 11201811154Q A SG11201811154Q A SG 11201811154QA SG 11201811154Q A SG11201811154Q A SG 11201811154QA
Authority
SG
Singapore
Prior art keywords
diphenylmethane derivative
producing diphenylmethane
producing
derivative
diphenylmethane
Prior art date
Application number
SG11201811154QA
Other languages
English (en)
Inventor
Hee-Kyoon Yoon
Se-Hwan Park
Ji-Sung Yoon
Soongyu Choi
Hee Jeong Seo
Eun-Jung Park
Younggyu Kong
Kwang-Seop Song
Min Ju Kim
So Ok Park
Original Assignee
Daewoong Pharmaceutical Co Ltd
Green Cross Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Pharmaceutical Co Ltd, Green Cross Corp filed Critical Daewoong Pharmaceutical Co Ltd
Publication of SG11201811154QA publication Critical patent/SG11201811154QA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D9/00Crystallisation
    • B01D9/005Selection of auxiliary, e.g. for control of crystallisation nuclei, of crystal growth, of adherence to walls; Arrangements for introduction thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B51/00Introduction of protecting groups or activating groups, not provided for in the preceding groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SG11201811154QA 2016-06-17 2017-06-15 Method for producing diphenylmethane derivative SG11201811154QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20160075910 2016-06-17
PCT/KR2017/006271 WO2017217792A1 (fr) 2016-06-17 2017-06-15 Procédé de production d'un dérivé de diphénylméthane

Publications (1)

Publication Number Publication Date
SG11201811154QA true SG11201811154QA (en) 2019-01-30

Family

ID=60664449

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201911782RA SG10201911782RA (en) 2016-06-17 2017-06-15 Method for producing diphenylmethane derivative
SG11201811154QA SG11201811154QA (en) 2016-06-17 2017-06-15 Method for producing diphenylmethane derivative

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201911782RA SG10201911782RA (en) 2016-06-17 2017-06-15 Method for producing diphenylmethane derivative

Country Status (29)

Country Link
US (2) US10640496B2 (fr)
EP (2) EP3663292B1 (fr)
JP (4) JP6763978B2 (fr)
KR (2) KR102233229B1 (fr)
CN (2) CN109311861B (fr)
AU (1) AU2017285813B2 (fr)
BR (1) BR112018076243A2 (fr)
CA (2) CA3081033C (fr)
CL (1) CL2018003645A1 (fr)
CO (1) CO2018014018A2 (fr)
DK (2) DK3663292T3 (fr)
DO (1) DOP2018000287A (fr)
EC (1) ECSP19000185A (fr)
ES (2) ES2891825T3 (fr)
HR (1) HRP20211670T8 (fr)
HU (1) HUE056428T2 (fr)
MA (2) MA50774B1 (fr)
MX (2) MX2018015647A (fr)
NZ (1) NZ749398A (fr)
PE (2) PE20190467A1 (fr)
PH (1) PH12018550206A1 (fr)
PL (2) PL3473621T3 (fr)
PT (2) PT3663292T (fr)
RS (1) RS62550B1 (fr)
SA (1) SA518400666B1 (fr)
SG (2) SG10201911782RA (fr)
SI (1) SI3663292T1 (fr)
TN (1) TN2018000437A1 (fr)
WO (1) WO2017217792A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102011054773A1 (de) 2011-10-25 2013-04-25 Vb Autobatterie Gmbh & Co. Kgaa Anschlusspol für einen Akkumulator, Akkumulatorgehäuse und Maschine zur Herstellung eines Anschlusspols
KR102307475B1 (ko) 2018-08-13 2021-09-30 주식회사 대웅제약 Sglt 저해제의 합성에 유용한 중간체의 제조
CN112341416A (zh) * 2019-08-09 2021-02-09 天津津艺医药科技发展有限责任公司 一种制备苯并含氧脂杂环衍生物的方法
CN115087649A (zh) 2020-02-27 2022-09-20 株式会社大熊制药 用于合成sglt抑制剂的中间体和使用该中间体制备sglt抑制剂的方法
WO2022051980A1 (fr) 2020-09-10 2022-03-17 广东莱佛士制药技术有限公司 Procédé de synthèse destiné à la préparation d'un intermédiaire des inhibiteurs de sglt
CN112094253B (zh) * 2020-09-10 2023-01-10 株式会社大熊制药 用于制备sglt抑制剂中间体的合成方法
CN113200860A (zh) * 2021-04-29 2021-08-03 爱斯特(成都)生物制药股份有限公司 一种sglt2抑制剂中间体的制备方法
CN113801010A (zh) * 2021-11-18 2021-12-17 山东诚创蓝海医药科技有限公司 一种5-溴-2-氯苯甲酸的制备方法
CN113912487B (zh) * 2021-11-23 2024-05-28 山东研峰新材料科技有限公司 一种2,5-双卤代苯甲酸的合成方法
KR20230110001A (ko) * 2022-01-14 2023-07-21 주식회사 대웅제약 Ssglt 저해제의 합성에 유용한 중간체의 제조 방법
KR20240044190A (ko) 2022-09-28 2024-04-04 주식회사 대웅제약 이나보글리플로진의 신규한 결정형 및 이의 제조방법
KR20240044194A (ko) * 2022-09-28 2024-04-04 주식회사 대웅제약 이나보글리플로진의 신규한 공결정

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4966907A (en) * 1988-08-12 1990-10-30 Merck & Co., Inc. 6-substituted 5-hydroxy-2,3-dihydrobenzofurans as inhibitors of leukotriene biosynthesis
NZ545304A (en) * 2003-08-01 2009-04-30 Mitsubishi Tanabe Pharma Corp Novel compounds having inhibitory activity against sodium-dependant transporter
CN101801989B (zh) 2007-07-26 2015-11-25 莱西肯医药有限公司 用于制备钠-葡萄糖协同转运蛋白2抑制剂的方法和化合物
CA2731405A1 (fr) * 2008-07-30 2010-02-04 Ferrer Internacional S.A. Composes 1,6-dihydro-2h-3-oxa-6-aza-as-indacene
US8163704B2 (en) 2009-10-20 2012-04-24 Novartis Ag Glycoside derivatives and uses thereof
WO2012041898A1 (fr) * 2010-09-29 2012-04-05 Celon Pharma Sp. Z O.O. Combinaison de l'inhibiteur de sglt2 et d'un composé de sucre pour le traitement du diabète
JP5876570B2 (ja) * 2011-06-01 2016-03-02 グリーン・クロス・コーポレイションGreen Cross Corp. Sglt2阻害剤としての新規のジフェニルメタン誘導体
US9340521B2 (en) * 2013-03-18 2016-05-17 Green Cross Corporation Method for dual inhibition of SGLT1 and SGLT2 using diphenylmethane derivatives
FR3017868A1 (fr) * 2014-02-21 2015-08-28 Servier Lab Derives d'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CA3081033A1 (fr) 2017-12-21
JP6763978B2 (ja) 2020-09-30
RS62550B1 (sr) 2021-12-31
JP2020117528A (ja) 2020-08-06
ES2898336T3 (es) 2022-03-07
CA3026756C (fr) 2021-03-02
MA44545B2 (fr) 2020-11-30
JP2021152054A (ja) 2021-09-30
TN2018000437A1 (en) 2020-06-15
US10640496B2 (en) 2020-05-05
HRP20211670T8 (hr) 2022-03-18
EP3473621A4 (fr) 2020-03-11
CN113651803A (zh) 2021-11-16
US10889574B2 (en) 2021-01-12
CN109311861B (zh) 2021-08-24
PL3473621T3 (pl) 2022-01-10
RU2019101056A3 (fr) 2020-07-17
RU2021129636A (ru) 2021-11-22
JP7352509B2 (ja) 2023-09-28
MX2021008988A (es) 2022-05-05
ES2891825T3 (es) 2022-01-31
SG10201911782RA (en) 2020-02-27
KR20170142904A (ko) 2017-12-28
CN113651803B (zh) 2022-10-28
AU2017285813A1 (en) 2019-01-17
NZ749398A (en) 2020-01-31
EP3473621B1 (fr) 2021-08-04
PT3473621T (pt) 2021-10-04
MX2018015647A (es) 2019-04-11
PE20240590A1 (es) 2024-03-21
RU2019101056A (ru) 2020-07-17
DOP2018000287A (es) 2019-03-31
PE20190467A1 (es) 2019-04-04
AU2017285813B2 (en) 2020-02-06
KR20210036892A (ko) 2021-04-05
CL2018003645A1 (es) 2019-03-22
EP3663292A1 (fr) 2020-06-10
US20190169174A1 (en) 2019-06-06
WO2017217792A1 (fr) 2017-12-21
JP2019521985A (ja) 2019-08-08
PH12018550206A1 (en) 2019-09-30
MA50774A1 (fr) 2021-03-31
US20190382390A1 (en) 2019-12-19
CN109311861A (zh) 2019-02-05
MA50774B1 (fr) 2022-02-28
DK3663292T3 (da) 2021-10-25
ECSP19000185A (es) 2019-01-31
KR102379584B1 (ko) 2022-03-29
DK3473621T3 (da) 2021-09-06
MA44545A1 (fr) 2019-10-31
HUE056428T2 (hu) 2022-02-28
BR112018076243A2 (pt) 2019-03-26
EP3473621A1 (fr) 2019-04-24
SA518400666B1 (ar) 2021-11-30
PT3663292T (pt) 2021-11-08
CA3081033C (fr) 2022-04-12
CA3026756A1 (fr) 2017-12-21
MA44545B1 (fr) 2020-05-29
HRP20211670T1 (hr) 2022-02-18
JP2023145481A (ja) 2023-10-11
SI3663292T1 (sl) 2022-01-31
EP3663292B1 (fr) 2021-09-01
CO2018014018A2 (es) 2019-03-08
KR102233229B1 (ko) 2021-03-29
PL3663292T3 (pl) 2022-01-17

Similar Documents

Publication Publication Date Title
SG11201811154QA (en) Method for producing diphenylmethane derivative
PT3352896T (pt) Método de produção de isocianatos
EP3333266A4 (fr) Procédé de production sélénoéine
IL266044B (en) Method for the production of 3-alkylsulfanyl-2-chloro-n-(1-alkyl-h1-tetrazol-5-yl)-4-trifluoromethyl-benzamides
PL3227023T3 (pl) Sposób wytwarzania kropel
EP3666729C0 (fr) Méthode de production de nano-soufre
EP3561067A4 (fr) Procédé de production d'urolithines
HUE046230T2 (hu) Titokzokni, valamint eljárás ilyen titokzokni gyártására
EP3296282A4 (fr) Procédé de production d'hydrohalofluorooléfines
IL252173A0 (en) Methods for the production of methyl dichlorophosphane
EP3275886A4 (fr) Procédé de production de dialkylaminosilane
SG11201701326YA (en) Method for producing oligosilane
IL264307B (en) Production method for a pyrazole-amide compound
HK1249098A1 (zh) 用於生產氟美他酚的方法
HK1256031A1 (zh) 新的4-苯並偶氮寧衍生物的製造方法
EP3118194A4 (fr) Procede de production de derive de 2-acyliminopyridine
EP3415499A4 (fr) Procédé de production de 1-méthylpyrrolidin-3-ol
HUE047039T2 (hu) Eljárás izocianátok elõállítására
ZA201805537B (en) Method for producing sulfoxide derivative
SG11201907182QA (en) Method for producing perfluoroalkadiene compounds
IL255093A0 (en) A method for the production of levoglucosenon
PL3448159T3 (pl) Sposób wytwarzania niesmażonych nuggetów
PL3511315T3 (pl) Sposób wytwarzania n-metylo-para-anizydyny
EP3398929A4 (fr) Procédé de production d' , -difluoroacétaldéhyde
PL3299394T3 (pl) Sposób wytwarzania zmodyfikowanych ksylopolisacharydów